logo-loader
RNS
British American Tobacco PLC

British Am. Tobacco - Publication of a Prospectus

RNS Number : 2730I
British American Tobacco PLC
31 March 2020
 

Publication of Prospectus

The following Base Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Base Prospectus dated 31 March 2020 (the "Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of B.A.T. International Finance p.l.c., B.A.T Capital Corporation and B.A.T. Netherlands Finance B.V. (as Issuers) and British American Tobacco p.l.c. and each of the Issuers (except where it is the relevant Issuer) (as Guarantors).

To view the Prospectus please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/2730I_1-2020-3-31.pdf

The full document has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

Enquiries

British American Tobacco Press Office 

+44 (0) 20 7845 2888 (24 hours) | @BATPress

 

Investor Relations 

Mike Nightingale/Victoria Buxton/William Houston/John Harney        

+44 20 7845 1180/2012/1138/1263

 

British American Tobacco p.l.c.
Globe House
4 Temple Place
London WC2R 2PG

31 March 2020

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PDIBXGDXCUXDGGB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read